- Development of an innovative cosmetic active ingredient combining the exclusive properties of Deinove’s strains and Oléos' patented Oleo-eco-extraction process
- Commercial launch planned for the end of 2018
DEINOVE (Euronext Growth Paris: ALDEI), a biotech company that discovers, develops, and produces high-value compounds from rare bacteria, announces a partnership with Hallstar’s Oléos group. The goal is to develop a new 100% natural cosmetic active ingredient combining the exclusive properties of DEINOVE bacteria and the patented Oleo-eco-extraction Oléos technology.
Oléos, which became part of Hallstar in 2016, has already developed, from its proprietary process, twenty or so active ingredients marketed to cosmetics brands in France and abroad, and continues to expand its range.
To this end, it has selected one of the active strains of the DEINOVE catalog, which offers interesting properties for cosmetics. DEINOVE will now work to optimize the strain production performance, while the Oléos team will formulate an innovative ingredient by applying its extraction process to this bacterial biomass. The objective is to obtain a stable oil-based active ingredient with clinically proven efficacy that is easy to formulate and conforms to the requirements of the cosmetics market. The commercial launch is scheduled for the end of 2018.
Anne ROSSIGNOL-CASTERA, Hallstar’s General and Scientific Manager for Oléos, said: "We were attracted by the innovative nature of DEINOVE's approach. The strain catalog is very promising in terms of diversity and efficiency, which fits perfectly with our differentiation strategy and innovation model."
Emmanuel PETIOT, CEO of DEINOVE, added: "This new partnership reinforces our strategy for the development of biosourced cosmetic ingredients. We are excited to collaborate with Oléos from Hallstar to develop what will be our third innovative active ingredient."